Danaher (NYSE:DHR) updated its FY18 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of $4.49-4.52 for the period, compared to the Thomson Reuters consensus estimate of $4.49. Danaher also updated its FY 2018 guidance to $4.49-4.52 EPS.
A number of research analysts have recently commented on the stock. Zacks Investment Research cut shares of Danaher from a hold rating to a sell rating in a research report on Monday, July 16th. ValuEngine cut shares of Danaher from a buy rating to a hold rating in a research report on Thursday, June 21st. Royal Bank of Canada boosted their target price on shares of Danaher to $107.00 and gave the stock a positive rating in a research report on Thursday, July 19th. They noted that the move was a valuation call. Morgan Stanley boosted their target price on shares of Danaher from $120.00 to $122.00 and gave the stock an overweight rating in a research report on Friday, July 20th. Finally, Bank of America set a $113.00 target price on shares of Danaher and gave the stock a buy rating in a research report on Thursday, July 19th. One analyst has rated the stock with a hold rating and fifteen have issued a buy rating to the stock. The stock currently has an average rating of Buy and a consensus price target of $111.57.
Shares of NYSE:DHR traded down $1.76 during midday trading on Thursday, reaching $103.20. The company had a trading volume of 86,725 shares, compared to its average volume of 2,383,910. The company has a current ratio of 1.50, a quick ratio of 1.07 and a debt-to-equity ratio of 0.41. The firm has a market cap of $76.04 billion, a PE ratio of 25.68, a price-to-earnings-growth ratio of 2.08 and a beta of 1.01. Danaher has a one year low of $85.10 and a one year high of $110.13.
Danaher (NYSE:DHR) last issued its quarterly earnings results on Thursday, October 18th. The conglomerate reported $1.10 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.07 by $0.03. The business had revenue of $4.85 billion during the quarter, compared to analyst estimates of $4.80 billion. Danaher had a net margin of 13.84% and a return on equity of 11.55%. The business’s revenue was up 7.2% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.00 earnings per share. As a group, equities research analysts forecast that Danaher will post 4.49 EPS for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Friday, October 26th. Investors of record on Friday, September 28th will be paid a $0.16 dividend. The ex-dividend date is Thursday, September 27th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 0.62%. Danaher’s dividend payout ratio (DPR) is presently 15.88%.
In related news, EVP William K. Daniel sold 103,086 shares of Danaher stock in a transaction on Friday, August 10th. The shares were sold at an average price of $100.63, for a total value of $10,373,544.18. Following the completion of the sale, the executive vice president now owns 167,080 shares in the company, valued at $16,813,260.40. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CFO Daniel L. Comas sold 77,407 shares of the business’s stock in a transaction on Thursday, July 26th. The shares were sold at an average price of $103.93, for a total transaction of $8,044,909.51. Following the sale, the chief financial officer now owns 135,218 shares of the company’s stock, valued at approximately $14,053,206.74. The disclosure for this sale can be found here. In the last 90 days, insiders sold 299,961 shares of company stock valued at $30,619,691. Insiders own 11.90% of the company’s stock.
Danaher Company Profile
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides laser scanning, compound, surgical, and other stereo microscopes. This segment also offers filtration, separation, and purification technologies to the biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial sectors.
Recommended Story: What are the Different Types of Leveraged Buyouts?
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.